pimagedine has been researched along with Cardiovascular Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Beheshti, F; Hadipanah, MR; Hashemzehi, M; Hosseini, M; Mahmoudabady, M | 1 |
| Micans, P | 1 |
| Merhi, Z; Pertynska-Marczewska, M | 1 |
| Kawakami, M; Kuroki, M | 1 |
| Aronson, D | 1 |
| McEniery, CM | 1 |
| Brown, L; Chan, V; Hoey, A | 1 |
| Ren, S; Shen, GX; Zhang, J | 1 |
2 review(s) available for pimagedine and Cardiovascular Diseases
| Article | Year |
|---|---|
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Topics: Cardiovascular Diseases; Cinnamates; Female; Glycation End Products, Advanced; Guanidines; Humans; Menopause; Receptor for Advanced Glycation End Products | 2015 |
[Aminoguanidine and other AGE inhibitors].
Topics: Amides; Animals; Arteriosclerosis; Cardiovascular Diseases; Cataract; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Retinopathy; Disease Models, Animal; Drug Design; Glycation End Products, Advanced; Guanidines; Humans; Hydrazines; Hypoglycemic Agents; Thiadiazoles; Thiazoles; Thiazolidines | 2002 |
1 trial(s) available for pimagedine and Cardiovascular Diseases
| Article | Year |
|---|---|
Aortic wave velocity: a noninvasive method to measure the stiffness of arteries and the clinical results of supplements that appear to improve arterial stiffness.
Topics: Adult; Aged; Aging; Arginine; Cardiovascular Diseases; Carnosine; Dietary Supplements; Female; Glycation End Products, Advanced; Guanidines; Humans; Male; Middle Aged; Pulse Wave Analysis; Resveratrol; Risk Factors; Stilbenes; Vascular Stiffness | 2013 |
5 other study(ies) available for pimagedine and Cardiovascular Diseases
| Article | Year |
|---|---|
The Cardioprotective Effects of Aminoguanidine on Lipopolysaccharide Induced Inflammation in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotoxicity; Cardiovascular Diseases; Cardiovascular System; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Inflammation; Inflammation Mediators; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats, Wistar | 2020 |
Pharmacological prevention of cardiovascular aging--targeting the Maillard reaction.
Topics: Aging; Animals; Cardiovascular Diseases; Coronary Vessels; Elasticity; Glycation End Products, Advanced; Glycosylation; Guanidines; Heart; Humans; Maillard Reaction; Myocardium; Ventricular Function, Left | 2004 |
Novel therapeutic strategies for reducing arterial stiffness.
Topics: Arteries; Cardiovascular Agents; Cardiovascular Diseases; Glycation End Products, Advanced; Guanidines; Hypertension | 2006 |
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Topics: Action Potentials; Animals; Aorta, Thoracic; Cardiovascular Diseases; Collagen; Cross-Linking Reagents; Desoxycorticosterone; Endothelium, Vascular; Guanidines; Heart Diseases; Hypertension; In Vitro Techniques; Male; Microelectrodes; Nephrectomy; Neutrophil Infiltration; Rats; Rats, Wistar; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2006 |
Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells.
Topics: Biomarkers; Blotting, Northern; Cardiovascular Diseases; Cells, Cultured; Diabetes Complications; Diabetes Mellitus; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysis; Glycation End Products, Advanced; Glycosylation; Guanidines; Humans; Lipoprotein(a); Lipoproteins, LDL; Nitric Oxide Synthase; Plasminogen Activator Inhibitor 1; Precipitin Tests; RNA, Messenger; Tissue Plasminogen Activator | 2000 |